Submitted:
08 May 2026
Posted:
08 May 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Design and Study Population
2.2. Sampling, Isolation and Bacterial Identification
2.3. Antimicrobial Susceptibility Testing
2.4. Definition of Accumulated Resistance and Multi-Resistance
2.5. Data Processing and Analytical Structure
2.6. Statistical Analysis
2.7. Methodological Considerations
2.8. Ethical Considerations
3. Results
3.1. Analytical Structure of the Dataset and Bacterial Composition of the Isolates
3.2. Antimicrobial Susceptibility Profile of Bacterial Isolates
3.3. Phenotypic Resistance Burden and Multidrug Resistance in Bacterial Isolates
3.4. Inferential Modeling of Resistance Accumulation in Gram-Negative Isolates
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| CLSI | Clinical and Laboratory Standards Institute |
| MDR | Multidrug resistance |
| GN | Gram-negative bacteria |
| GP | Gram-positive bacteria |
References
- Caneschi, A.; Bardhi, A.; Barbarossa, A.; Zaghini, A. The Use of Antibiotics and Antimicrobial Resistance in Veterinary Medicine, a Complex Phenomenon: A Narrative Review. Antibiotics 2023, 12, 487. [Google Scholar] [CrossRef]
- Endale, H.; Mathewos, M.; Abdeta, D. Potential Causes of Spread of Antimicrobial Resistance and Preventive Measures in One Health Perspective-A Review. Infect. Drug Resist. 2023, 16, 7515–7545. [Google Scholar] [CrossRef]
- Monteiro, H.I.G.; Silva, V.; de Sousa, T.; Calouro, R.; Saraiva, S.; Igrejas, G.; Poeta, P. Antimicrobial Resistance in European Companion Animals Practice: A One Health Approach. Animals 2025, 15, 1708. [Google Scholar] [CrossRef]
- Al-Khalaifah, H.; Rahman, M.H.; Al-Surrayai, T.; Al-Dhumair, A.; Al-Hasan, M. A One-Health Perspective of Antimicrobial Resistance (AMR): Human, Animals and Environmental Health. Life 2025, 15, 1598. [Google Scholar] [CrossRef] [PubMed]
- Kang, S.; Chen, Y.; Liu, M. The Role of Companion Animals as ‘Sentinels’ From the One Health Perspective. Vet. Med. Sci. 2026, 12, e70814. [Google Scholar] [CrossRef]
- Portilho, F.V.R.; Nóbrega, J.; de Almeida, B.O.; Mota, A.R.; de Paula, C.L.; Listoni, F.J.P.; Bosco, S.M.G.; Oliveira, A.L.; Cunha, M. de L.R.S.; Ribeiro, M.G. Microbial Complexity of Oral Cavity of Healthy Dogs Identified by Mass Spectrometry and Next-Generation Sequencing. Animals 2023, 13, 2467. [Google Scholar] [CrossRef]
- Zhao, R.; Hao, J.; Yang, J.; Tong, C.; Xie, L.; Xiao, D.; Zeng, Z.; Xiong, W. The Co-Occurrence of Antibiotic Resistance Genes between Dogs and Their Owners in Families. iMeta 2022, 1, e21. [Google Scholar] [CrossRef]
- Lee, G.Y.; Jo, H.Y.; Abbas, M.A.; Gui, L.; Ali, M.S.; Kim, S.J.; Park, S.C. Microbiota Analysis and Characterisation of the Novel Limosilactobacillus Strains Isolated from Dogs. Microorganisms 2025, 13, 1059. [Google Scholar] [CrossRef]
- Yang, S. Bin; Moon, J.-H. Microbial Therapeutics for Canine Periodontal Disease: Current Status and Future Perspectives. Front. Vet. Sci. 2026, 12, 1748968. [Google Scholar] [CrossRef] [PubMed]
- Beaulac, K.; Fellman, C.L.; Wayne, A.S.; Mcdermott, L.A.; Snydman, D.R.; Doron, S. Impact of Antimicrobial Use in Dogs on Antimicrobial Resistance and Shared Flora with Human Owners. Antimicrob. Steward. Healthc. Epidemiol. 2023, 3, e1. [Google Scholar] [CrossRef] [PubMed]
- Bourély, C.; Cazeau, G.; Jarrige, N.; Leblond, A.; Madec, J.Y.; Haenni, M.; Gay, E. Antimicrobial Resistance Patterns of Bacteria Isolated from Dogs with Otitis. Epidemiol. Infect. 2019, 147, e121. [Google Scholar] [CrossRef] [PubMed]
- Horodyska, I.; Kasperska, P.; Michalski, K.; Bubak, J.; Herman, I.; Miszczak, M. Natural Microbiota of Dogs and Cats as a Source and Vector of Resistance Genes—Clinical Significance. Int. J. Mol. Sci. 2025, 26, 7717. [Google Scholar] [CrossRef]
- Menezes, J.; Fernandes, L.; Marques, C.; Pomba, C. The Public Health Risks of Colistin Resistance in Dogs and Cats: A One Health Perspective Review. Antibiotics 2025, 14, 1213. [Google Scholar] [CrossRef]
- Mihu, M.L.; Nadăş, G.C.; Bouari, C.M.; Fiț, N.I.; Răpuntean, S. Klebsiella Pneumoniae Infections in Dogs: A One Health Review of Antimicrobial Resistance, Virulence Factors, Zoonotic Risk, and Emerging Alternatives. Microorganisms 2026, 14, 149. [Google Scholar] [CrossRef]
- Santibáñez, R.; Rodríguez-Salas, C.; Flores-Yáñez, C.; Garrido, D.; Thomson, P.; Requicha, F.; Alberto, C.; Viegas, A.; San, F.; Ascaso, R. Assessment of Changes in the Oral Microbiome That Occur in Dogs with Periodontal Disease. Vet. Sci. 2021, 8, 291. [Google Scholar] [CrossRef]
- Oh, C.; Lee, K.; Cheong, Y.; Lee, S.W.; Park, S.Y.; Song, C.S.; Choi, I.S.; Lee, J.B. Comparison of the Oral Microbiomes of Canines and Their Owners Using Next-Generation Sequencing. PLoS ONE 2015, 10, e0131468. [Google Scholar] [CrossRef] [PubMed]
- Kim, H.; Chae, Y.; Cho, J.H.; Song, M.; Kwak, J.; Doo, H.; Choi, Y.; Kang, J.; Yang, H.; Lee, S.; et al. Understanding the Diversity and Roles of the Canine Gut Microbiome. J. Anim. Sci. Biotechnol. 2025 16:1 2025, 16, 95. [Google Scholar] [CrossRef] [PubMed]
- Targońska-Karasek, M.; Polkowska, I.; Krukowski, H. Is Pseudomonas Aeruginosa a Possible Aetiological Agent of Periodontitis in Dogs? J. Vet. Res. 2025, 69, 35–40. [Google Scholar] [CrossRef]
- Alhumaid, S.; Al Mutair, A.; Al Alawi, Z.; Alzahrani, A.J.; Tobaiqy, M.; Alresasi, A.M.; Bu-Shehab, I.; Al-Hadary, I.; Alhmeed, N.; Alismail, M.; et al. Antimicrobial Susceptibility of Gram-Positive and Gram-Negative Bacteria: A 5-Year Retrospective Analysis at a Multi-Hospital Healthcare System in Saudi Arabia. Ann. Clin. Microbiol. Antimicrob. 2021, 20 20, 43. [Google Scholar] [CrossRef]
- Danieli, D.; Amadori, M.; Crimi, S.; Pregnolato, F.; Caruso, C.; Gambino, G.; Re, G.; Vercelli, C. Antimicrobial Resistant Isolates in Surgical and Bite Wounds in Dogs and Cats: A 12-Year Retrospective Analysis. Animals 2026, 16, 501. [Google Scholar] [CrossRef] [PubMed]
- Putriningsih, P.A.S.; Kampa, J.; Jittimanee, S.; Phuektes, P. Characterization of Oxacillin-Resistant and Oxacillin-Susceptible MecA-Positive Staphylococcus Pseudintermedius from Skin Lesions and Nasal Cavities of Dogs with Clinical Pyoderma. Animals 2024, 14, 2613. [Google Scholar] [CrossRef]
- Rzewuska, M.; Czopowicz, M.; Kizerwetter-͆wida, M.; Chrobak, D.; Błaszczak, B.; Binek, M. Multidrug Resistance in Escherichia Coli Strains Isolated from Infections in Dogs and Cats in Poland (2007–2013). Sci. World J. 2015, 2015, 408205. [Google Scholar] [CrossRef]
- Ribeiro, J.; Lameiras, R.; Silva, V.; Igrejas, G.; Nunes, F.C.; Ribeiro, A.I.; Mateus, T.L.; Poeta, P. Occurrence and Characterization of Antimicrobial-Resistant and Virulent Enterococcus Spp. in Dog Feces from Urban Green Spaces in Porto (Portugal). Antibiotics 2026, 15, 379. [Google Scholar] [CrossRef] [PubMed]
- Gołyńska, M.; Polkowska, I.; Bartoszcze-Tomaszewska, M.; Sobczyńska-Rak, A.; Matuszewski, Ł. Molecular-Level Evaluation of Selected Periodontal Pathogens from Subgingival Regions in Canines and Humans with Periodontal Disease. J. Vet. Sci. 2017, 18, 51–58. [Google Scholar] [CrossRef] [PubMed]
- Tóth, A.G.; Tóth, D.L.; Remport, L.; Tóth, I.; Németh, T.; Dubecz, A.; Patai, Á. V.; Wagenhoffer, Z.; Makrai, L.; Solymosi, N. A One Health Approach Metagenomic Study on Antimicrobial Resistance Traits of Canine Saliva. Antibiotics 2025, 14, 433. [Google Scholar] [CrossRef] [PubMed]






| Bacterium | n | % |
| Staphylococcus aureus | 48 | 34.5 |
| Pseudomonas | 38 | 27.3 |
| Klebsiella | 29 | 20.9 |
| Enterobacter | 11 | 7.9 |
| Salmonella | 9 | 6.5 |
| Escherichia coli | 4 | 2.9 |
| Total | 139 | 100.0 |
| Antibiotic |
Susceptible n (%) |
Resistant n (%) |
| Ampicillin /sulbactam (GN) | 43 (47.3) | 48 (52.7) |
| Tetracycline | 44 (48.4) | 47 (51.6) |
| Trimethoprim-sulfamethoxazole | 54 (59.3) | 37 (40.7) |
| Ceftriaxone | 80 (87.9) | 11 (12.1) |
| Streptomycin | 53 (58.2) | 38 (41.8) |
| Penicillin (GP) | 25 (52.1) | 23 (47.9) |
| Oxacillin | 48 (100.0) | 0 (0.0) |
| Ampicillin /sulbactam (GP) | 48 (100.0) | 0 (0.0) |
| Cefoxitin | 48 (100.0) | 0 (0.0) |
| Variable | n/N | % |
| Isolates with resistance to at least one antimicrobial, total dataset | 99/139 | 71.2 |
| Multidrug resistant isolates in the total dataset | 13/139 | 9.4 |
| Gram negative isolates with resistance to at least one class | 76/91 | 83.5 |
| Gram negative isolates with resistance to at least two classes | 39/91 | 42.9 |
| Gram-negative multidrug resistant isolates | 13/91 | 14.3 |
| Gram-positive multidrug resistant isolates | 0/48 | 0.0 |
| Preacher | Adjusted OR | 95% CI | p |
| Klebsiella vs Pseudomonas | 0.70 | 0.22–2.26 | 0.549 |
| Enterobacter vs Pseudomonas | 16.30 | 1.69–157.14 | 0.016 |
| Salmonella vs Pseudomonas | 0.91 | 0.18–4.66 | 0.909 |
| Escherichia coli vs Pseudomonas | 5.35 | 0.46–62.87 | 0.182 |
| Age, per additional year | 0.92 | 0.70–1.21 | 0.549 |
| Female sex vs male sex | 0.73 | 0.23–2.25 | 0.580 |
| Balanced diet vs non balanced diet | 1.24 | 0.40–3.80 | 0.710 |
| Gingivitis grade 3 vs grades 1–2 | 1.28 | 0.28–5.81 | 0.745 |
| Advanced periodontitis vs grades 0–2 | 1.34 | 0.21–8.44 | 0.756 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).